{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:19Z","timestamp":1791215479619,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010129","name":"Maud Kuistila Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijid.2026.108891","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:32:47Z","timestamp":1781713967000},"page":"108891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serologic responses in patients with invasive group a streptococcal disease"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-2782","authenticated-orcid":false,"given":"Ville","family":"Kailankangas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Gr\u00f6ndahl-Yli-Hannuksela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Vilhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisu","family":"Rantakokko-Jalava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapio","family":"Seiskari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"L\u00f6nnqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmo","family":"Oksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Syrj\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Vuopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108891_bib0001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.puhe.2020.06.007","article-title":"Invasive group A streptococcal infections in North West England: epidemiology, risk factors and fatal infection","volume":"186","author":"Blagden","year":"2020","journal-title":"Public Health"},{"issue":"2","key":"10.1016\/j.ijid.2026.108891_bib0002","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of group A Streptococcus","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.ijid.2026.108891_bib0003","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1073\/pnas.0406641102","article-title":"Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response","volume":"102","author":"Sumby","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ijid.2026.108891_bib0004","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CDLI.6.1.133-136.1999","article-title":"Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains","volume":"6","author":"Eriksson","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.ijid.2026.108891_bib0005","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00006454-200205000-00014","article-title":"Clinical use and interpretation of group A streptococcal antibody tests: a practical approach for the pediatrician or primary care physician","volume":"21","author":"Shet","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.ijid.2026.108891_bib0006","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/23744235.2023.2192287","article-title":"Presence of Streptococcus pyogenes in the throat in invasive Group A streptococcal disease: a prospective two-year study in two health districts, Finland","volume":"55","author":"Kailankangas","year":"2023","journal-title":"Infect Dis (Lond)"},{"issue":"1","key":"10.1016\/j.ijid.2026.108891_bib0007","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s15010-024-02318-6","article-title":"Low expression of the CCL5 gene and low serum concentrations of CCL5 in severe invasive group a streptococcal disease","volume":"53","author":"Kailankangas","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2026.108891_bib0008","unstructured":"CDC Streptococcus laboratory: M protein gene (emm) typing. Available at: https:\/\/www.cdc.gov\/streplab\/groupa-strep\/emm-background.html. Accessed 4 October 2021."},{"key":"10.1016\/j.ijid.2026.108891_bib0009","unstructured":"ABIM. American Board of Internal Medicine Laboratory Test Reference Ranges. ABIM; 2024. Available at: https:\/\/www.abim.org\/Media\/bfijryql\/laboratory-reference-ranges.pdf. Accessed 5 February 2026."},{"issue":"5\u20136","key":"10.1016\/j.ijid.2026.108891_bib0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00430-022-00750-9","article-title":"Low rate of asymptomatic carriage and salivary immunoglobulin A response to group A streptococci in the healthy adult population in Finland","volume":"211","author":"L\u00f6nnqvist","year":"2022","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ijid.2026.108891_sbref0011","series-title":"A-ryhm\u00e4n streptokokin esiintyvyys Suomessa","year":"2024"},{"key":"10.1016\/j.ijid.2026.108891_bib0012","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108891_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-022-00593-8","article-title":"Correlates of immunity to group A Streptococcus: a pathway to vaccine development","volume":"8","author":"Frost","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ijid.2026.108891_bib0014","article-title":"Serological responses to target Streptococcus pyogenes vaccine antigens in patients with proven invasive beta-haemolytic streptococcal infections","author":"Langworthy","year":"2024","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2026.108891_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02486-22","article-title":"Invasive streptococcal infection can lead to the generation of cross-strain opsonic antibodies","volume":"10","author":"de Neergaard","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"4","key":"10.1016\/j.ijid.2026.108891_bib0016","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1086\/650167","article-title":"The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications","volume":"50","author":"Johnson","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2026.108891_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/jpids\/piaf054","article-title":"Streptococcal serology reference intervals in an Australian pediatric cohort","volume":"14","author":"Tsoi","year":"2025","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"10.1016\/j.ijid.2026.108891_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54665-5","article-title":"Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections","volume":"15","author":"Osowicki","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2026.108891_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113194","article-title":"An eight-plex immunoassay for group A streptococcus serology and vaccine development","volume":"500","author":"Whitcombe","year":"2022","journal-title":"J Immunol Methods"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:57:21Z","timestamp":1791212241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226005266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":19,"alternative-id":["S1201971226005266"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108891","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serologic responses in patients with invasive group a streptococcal disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108891"}}